Posted on 5/11/20
Akebia Therapeutics Proposes Public Offering of Common Stock
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced the commencement of . . .
Posted on 5/11/20
Sarepta Therapeutics and Dyno Therapeutics Announce Agreement to Develop Next-Generation Gene Therapy Vectors
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, and Dyno Therapeutics, Inc., a biotech company applying artificial intelligence (AI) to gene . . .
Posted on 5/11/20
Dyno Therapeutics Announces Ocular Collaboration with Novartis
Dyno Therapeutics, a biotechnology company applying artificial intelligence (AI) to gene therapy, today announced a collaboration with Novartis to develop improved Adeno-Associated Virus (AAV) vectors for . . .
Posted on 5/11/20
Aileron Therapeutics Reports Q1 2020 Financial Results and Provides Corporate Update
WATERTOWN, Mass., May 11, 2020 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN) today reported business highlights and financial results for the first quarter ended March 31, 2020.“We . . .
Posted on 5/11/20
bluebird bio Provides Operational and Business Update and Reports First Quarter 2020 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) today reported financial results and business highlights for the first quarter ended March 31, 2020 and provided an operational . . .
Posted on 5/11/20
Evelo Biosciences Reports First Quarter Financial Results and Business Highlights
CAMBRIDGE, Mass., May 11, 2020 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting . . .
Posted on 5/11/20
View Press ReleaseSesen Bio Reports First Quarter 2020 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported operating results . . .
Posted on 5/11/20
Bristol-Myers Squibb: This Could Be The Next Quarter Trillion Dollar Company
SummaryBristol-Myers Squibb has actually seen improved performance as a result of COVID-19. That's perfect as the company is paying off a big acquisition.BMY has a market . . .
Posted on 5/11/20
Boston Scientific: Start Building A Position In This Beaten-Down Medtech Company
SummaryDelayed elective procedures can result in magnified demand for some of BSX’s products in coming months.Boston Scientific is one of the few medtech companies well positioned . . .
Posted on 5/11/20
3 Reasons to Buy Vertex Pharmaceuticals Stock Right Now
Vertex Pharmaceuticals (NASDAQ:VRTX), a biotech company that holds a monopoly in the market for drugs that treat cystic fibrosis (CF), reported strong first quarter results on . . .
Posted on 5/10/20
Cape Cod Hospital Announces Furloughs of 600 Workers
Registered nurses who work for Cape Cod Health Care, including nurses at Cape Cod and Falmouth Hospitals and the Cape Cod VNA, are alarmed and outraged . . .
Posted on 5/9/20
Spero Therapeutics to Provide Business Update
CAMBRIDGE, Mass., May 04, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in . . .
Posted on 5/8/20
Synlogic Reports First Quarter 2020 Financial Results and Provides Business Update
Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, today reported its financial results for the . . .
Posted on 5/8/20
Ocular Therapeutix Reports First Quarter 2020 Financial Results and Business Update
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the . . .
Posted on 5/8/20
Mersana Therapeutics Announces First Quarter 2020 Financial Results and Provides Business Update
CAMBRIDGE, Mass., May 08, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates . . .
Posted on 5/8/20
3 Reasons Bristol Myers Squibb's Revenue Skyrocketed in Q1
Bristol Myers Squibb (NYSE:BMY) announced its first-quarter results before the market opened on Thursday. The big pharma company did exactly what it needed to, delivering strong . . .
Posted on 5/8/20
Vapotherm Prices Public Offering of Common Stock
EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used . . .
Posted on 5/8/20
X4 Pharmaceuticals Provides Corporate Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, . . .
Posted on 5/7/20
Tracking Risk of COVID-19 Stimulus Packages
Signed into law on March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act, or CARES Act, an amendment to the Small Business Act, is . . .
Posted on 5/7/20
Selecta Biosciences Reports Q1 2020 Financial Results
WATERTOWN, Mass., May 07, 2020 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies . . .
Posted on 5/7/20
Intellia Therapeutics Announces Q1 2020 Financial Results
CAMBRIDGE, Mass., May 07, 2020 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both . . .
Posted on 5/7/20
Reports Q1 2020 Financial Results and Provides Business Update
BOSTON, May 07, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today provided . . .
Posted on 5/7/20
Momenta Pharmaceuticals Reports First Quarter 2020 Financial and Operating Results
CAMBRIDGE, Mass., May 07, 2020 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat . . .
Posted on 5/7/20
Cerence Announces Second Quarter 2020 Results
BURLINGTON, Mass., May 07, 2020 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today reported its second fiscal quarter 2020 results . . .
Posted on 5/7/20
Imara Reports First Quarter 2020 Financial Results and Business Highlights
BOSTON, May 07, 2020 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering . . .

